Power supplier Aggreko accepts £2.3bn private equity bid
Aggreko looks set to become the latest British business to fall into the hands of private equity after the board of the mobile power specialist recommended a £2.3bn bid. Management, led by chairman Ken Hanna, said the offer of 880p a share from a consortium of I Squared of the US and TDR Capital of […]
TPG stares at perfect 10 for Novotech
Private equity firm TPG Capital is eyeing about 10-times its money at clinical trials business Novotech. It is understood the firm’s recent minority stake sale locked in a valuation at about 7½ times TPG’s initial investment, and recent momentum and equity market movements had it eyeing up to a stonking 10-times return should Novotech list in […]
Permira bids for $3.7bn medical device maker LivaNova
The private equity group Permira has bid to acquire LivaNova, the US-listed medical devices manufacturer, two people familiar with the matter said. The offer, made in mid-February, values the company’s shares at more than $80, the people said. That marks a premium to their $75 price on Wednesday, which gave the company a $3.7bn market […]
Schneider, AES investment takes Uplight’s valuation to $1.5 billion
A consortium of investors led by French electrical equipment group Schneider Electric and U.S. electric utility AES Corp are investing in Uplight, valuing the utility software firm at $1.5 billion, the companies said on Wednesday. A group of private equity investors led by Huck Capital will also participate in the funding round. Uplight, which makes […]
Apollo Global Management and GIP bid for stake in Aramco’s oil pipelines
Apollo Global Management and Global Infrastructure Partners (GIP) are reportedly among companies that have placed a bid for a $10bn stake in Saudi Aramco’s oil pipelines. Brookfield Asset Management, investment management company BlackRock, China Investment, and Silk Road Fund also made non-binding offers for these assets, Bloomberg reported, citing undisclosed sources. The report added that […]
BC Weighs Sale of $1.8 Billion Drugmaker Pharmathen
BC Partners is weighing a sale of European generic drugmaker Pharmathen, which could be valued at as much as 1.5 billion euros ($1.8 billion), according to people familiar with the matter. The private equity firm is speaking with potential advisers as it considers options for the business, the people said, asking not to be identified […]
SoftBank-Backed Loggi Valued Near $2 Billion in Fundraising
Brazilian delivery startup Loggi Tecnologia Ltda, which is backed by SoftBank Group Corp. and Microsoft Corp., raised 1.15 billion reais ($205 million) in its latest funding round that now values the company at close to $2 billion. The new round, the company’s largest yet, was led by CapSur Capital and included renowned Brazilian hedge fund manager […]
Perrigo to sell generic drugs business for $1.55 billion
Perrigo Company Plc on Monday posted quarterly earnings below estimates and said it would sell its underperforming generic drugs business for $1.55 billion, as the consumer healthcare products company sharpens focus on its core business. The sale, to private equity firm Altaris Capital Partners, is expected to close by the end of the third quarter, […]
Liverpool owner FSG valued at ‘more than US$7bn’ in RedBird investment deal
Fenway Sports Group (FSG) is on the cusp of selling a ten per cent stake to private equity firm RedBird Capital Partners for around US$750 million, according to Sportico. The US-based outlet reports that the deal with RedBird, which was founded in 2013 by former Goldman Sachs banker Gerry Cardinale, would value the owner of Premier […]
Wells Fargo sells asset manager for US$2.1B to reshape bank
Wells Fargo & Co. plans to sell its asset-management business to two private equity firms, part of Chief Executive Officer Charlie Scharf’s efforts to dump non-essential operations and help the bank emerge from years of scandals. GTCR LLC and Reverence Capital Partners agreed to buy Wells Fargo Asset Management for US$2.1 billion, according to a […]
